产品名称
柠檬酸钾 三元 一水合物, meets USP testing specifications
Agency
USP/NF
meets USP testing specifications
质量水平
方案
100.10%
表单
crystals
mp
275 °C (dec.) (lit.)
应用
pharmaceutical (small molecule)
SMILES字符串
O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI
1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3
InChI key
PJAHUDTUZRZBKM-UHFFFAOYSA-K
正在寻找类似产品? 访问 产品对比指南
一般描述
一水合柠檬酸钾 (KCTM) 是一种钾盐,据报道可与 UCON 50-HB-5100(一种无规共聚物)有效形成双水相体系 (ATPS)。该产品是符合USP(美国药典)测试规范的高质量药典产品。它可以用于科研和试验研究。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
(Liquid+ liquid) equilibria of polymer-salt aqueous two-phase systems for laccase partitioning: UCON 50-HB-5100 with potassium citrate and (sodium or potassium) formate at 23?C.
Lladosa E, et al.
The Journal of Chemical Thermodynamics, 55, 166-171 (2012)
Clay Mechlin et al.
Journal of endourology, 25(9), 1541-1545 (2011-08-06)
Oral citrate supplements have been shown to decrease kidney stone recurrence rates in both laboratory and clinical studies. The taste of the citrate supplements, however, is poor, and long-term compliance is low. Our objective was to determine if Splenda(®) added
Chao-Yang Duan et al.
International journal of nanomedicine, 8, 909-918 (2013-03-08)
The property changes of urinary nanocrystallites in 13 patients with calcium oxalate (CaOx) stones were studied before and after ingestion of potassium citrate (K3cit), a therapeutic drug for stones. The analytical techniques included nanoparticle size analysis, transmission electron microscopy, X-ray
Naim M Maalouf et al.
The Journal of clinical endocrinology and metabolism, 96(12), 3733-3740 (2011-10-07)
Dietary intake of animal proteins is associated with an increase in urinary calcium and nephrolithiasis risk. We tested the hypothesis that the acid load imposed by dietary proteins causes this hypercalciuria. In a short-term crossover metabolic study, an alkali salt
Donna J Claes et al.
Pediatric nephrology (Berlin, Germany), 27(11), 2031-2038 (2012-01-28)
Cystinuria is a relatively uncommon cause of pediatric stone disease, but has significant morbidity if not properly controlled because of its significant stone recurrence rate. Cystinuria is caused by the inability of the renal tubules to reabsorb filtered cystine, which
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持